Egetis Therapeutics AB (publ) (EGTX.ST)
SEK 6.65
(-8.65%)
SEK 6.65
(-8.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.27 SEK | -29.59% |
| 2022 | -0.98 SEK | -68.97% |
| 2021 | -0.58 SEK | 76.23% |
| 2020 | -2.44 SEK | -125.93% |
| 2019 | -1.08 SEK | 31.65% |
| 2018 | -1.58 SEK | 3.07% |
| 2017 | -1.63 SEK | -40.52% |
| 2016 | -1.16 SEK | 17.14% |
| 2015 | -1.40 SEK | 13.04% |
| 2014 | -1.61 SEK | -75.0% |
| 2013 | -0.92 SEK | 25.81% |
| 2012 | -1.24 SEK | 17.33% |
| 2011 | -1.50 SEK | 85.48% |
| 2010 | -10.33 SEK | -146.54% |
| 2009 | -4.19 SEK | -14653.52% |
| 2008 | -0.03 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.25 SEK | 3.85% |
| 2024 Q1 | -0.26 SEK | 13.33% |
| 2023 FY | - SEK | -29.59% |
| 2023 Q2 | -0.32 SEK | -3.23% |
| 2023 Q1 | -0.31 SEK | 13.89% |
| 2023 Q3 | -0.35 SEK | -9.37% |
| 2023 Q4 | -0.30 SEK | 14.29% |
| 2022 Q1 | -0.16 SEK | 0.0% |
| 2022 FY | - SEK | -68.97% |
| 2022 Q4 | -0.36 SEK | -50.0% |
| 2022 Q3 | -0.24 SEK | -50.0% |
| 2022 Q2 | -0.16 SEK | 0.0% |
| 2021 Q2 | -0.19 SEK | -72.73% |
| 2021 Q3 | -0.13 SEK | 31.58% |
| 2021 Q4 | -0.16 SEK | -23.08% |
| 2021 Q1 | -0.11 SEK | 92.09% |
| 2021 FY | - SEK | 76.23% |
| 2020 Q2 | -0.62 SEK | 15.07% |
| 2020 FY | - SEK | -125.93% |
| 2020 Q4 | -1.39 SEK | -230.95% |
| 2020 Q1 | -0.73 SEK | -69.77% |
| 2020 Q3 | -0.42 SEK | 32.26% |
| 2019 Q1 | 0.43 SEK | 195.56% |
| 2019 FY | - SEK | 31.65% |
| 2019 Q2 | -0.52 SEK | -220.93% |
| 2019 Q3 | -0.54 SEK | -3.85% |
| 2019 Q4 | -0.43 SEK | 20.37% |
| 2018 Q3 | -0.35 SEK | 32.69% |
| 2018 Q4 | -0.45 SEK | -28.57% |
| 2018 FY | - SEK | 3.07% |
| 2018 Q1 | -0.29 SEK | 55.38% |
| 2018 Q2 | -0.52 SEK | -79.31% |
| 2017 FY | - SEK | -40.52% |
| 2017 Q4 | -0.65 SEK | -27.45% |
| 2017 Q3 | -0.51 SEK | -70.0% |
| 2017 Q2 | -0.30 SEK | -30.43% |
| 2017 Q1 | -0.23 SEK | 42.5% |
| 2016 Q1 | -0.22 SEK | 29.03% |
| 2016 FY | - SEK | 17.14% |
| 2016 Q4 | -0.40 SEK | -60.0% |
| 2016 Q3 | -0.25 SEK | 34.21% |
| 2016 Q2 | -0.38 SEK | -72.73% |
| 2015 Q3 | -0.36 SEK | 0.0% |
| 2015 FY | - SEK | 13.04% |
| 2015 Q1 | -0.39 SEK | 40.0% |
| 2015 Q2 | -0.36 SEK | 7.69% |
| 2015 Q4 | -0.31 SEK | 13.89% |
| 2014 Q2 | -0.43 SEK | -86.96% |
| 2014 Q1 | -0.23 SEK | 17.86% |
| 2014 Q4 | -0.65 SEK | -75.68% |
| 2014 Q3 | -0.37 SEK | 13.95% |
| 2014 FY | - SEK | -75.0% |
| 2013 Q2 | -0.22 SEK | 26.67% |
| 2013 FY | - SEK | 25.81% |
| 2013 Q4 | -0.28 SEK | -64.71% |
| 2013 Q3 | -0.17 SEK | 22.73% |
| 2013 Q1 | -0.30 SEK | 9.09% |
| 2012 Q2 | -0.39 SEK | -14.71% |
| 2012 FY | - SEK | 17.33% |
| 2012 Q4 | -0.33 SEK | -57.14% |
| 2012 Q3 | -0.21 SEK | 46.15% |
| 2012 Q1 | -0.34 SEK | 59.04% |
| 2011 Q2 | -0.14 SEK | 0.0% |
| 2011 Q1 | -0.14 SEK | 96.66% |
| 2011 Q4 | -0.83 SEK | -792.47% |
| 2011 FY | - SEK | 85.48% |
| 2011 Q3 | -0.09 SEK | 33.57% |
| 2010 Q2 | -2.32 SEK | -38.92% |
| 2010 Q1 | -1.67 SEK | 0.0% |
| 2010 Q4 | -4.19 SEK | -93.09% |
| 2010 FY | - SEK | -146.54% |
| 2010 Q3 | -2.17 SEK | 6.47% |
| 2009 FY | - SEK | -14653.52% |
| 2008 FY | - SEK | 0.0% |